Strain Information | |
---|---|
Image | ![]() |
BRC No. | RBRC02716 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.129X1-Plce1<tm1Tkat> |
Former Common name | PLCεKO |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | black [a/a B/B C/C] |
Strain development | Developed by Drs. T. Kataoka, N. Suzuki and H. Saito in 2001. |
Strain description | Phospholipase Cepsilon is a novel class of phosphoinositide-specific phospholipase C that were identified as a downstream effector of Ras and Rap small GTPases. This knockout strain expesses a phospolipase Cepsilon catalytically inactivated by gene targeting. Homozygous mutant mice show a congenital semilunar valvulogenesis defect. |
Colony maintenance | Backcross to C57BL/6 (Heterozygote x C57BL/6JJcl) |
References | Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Bai Y, Edamatsu H, Maeda S, Saito H, Suzuki N, Satoh T, Kataoka T Cancer Res., 15, 8808-8810 (2004). 15604236Congenital semilunar valvulogenesis defect in mice deficient in phospholipase C epsilon. Tadano M, Edamatsu H, Minamisawa S, Yokoyama U, Ishikawa Y, Suzuki N, Saito H, Wu D, Masago-Toda M, Yamawaki-Kataoka Y, Setsu T, Terashima T, Maeda S, Satoh T, Kataoka T Mol. Cell Biol., 25, 2191-2199 (2005). 15743817 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Plce1 MGI:1921305 | phospholipase C, epsilon 1 | 19 | Plce1<tm1Tkat> MGI:3525208 | targeted mutation 1, Tohru Kataoka | |||
neo | neomycin resistance gene (E. coli) | 19 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 8 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, SV40 late gene polyA signal, mouse Plce1 genomic DNA |
Research application | Cardiovascular Research Mouse Models for Human Disease |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Mol. Cell Biol., 25, 2191-2199 (2005). Cancer Res., 64, 8808-8810 (2004). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for publication of research papers. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use with the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Tohru Kataoka (Kobe University) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |